Role of EUS in the Evaluation of Luminal Cancer

Comprehensive Summary: Role of EUS in the Evaluation of Luminal Cancer

1. Main Clinical Topics Discussed

• Endoscopic ultrasound (EUS) staging of esophageal cancer (primary focus), with brief reference to gastric and rectal cancer
• Applied anatomy and lymphatic drainage of the esophagus as it relates to staging
• TNM staging using EUS across T1–T4 and N1–N3 disease
• Mediastinal invasion assessment and M-staging
• Role of EUS in restaging post-chemoradiation

2. Key Learning Points, Guidelines, and Recommendations

Anatomical Framework

• The esophagus is divided into four segments: cervical, upper, mid, and lower, delineated by the sternal notch, azygos vein, and inferior pulmonary vein
• Lymphatic drainage travels predominantly cranially and rightward through the thoracic duct and bronchomediastinal trunks, ultimately draining into the jugular-subclavian junction
• Submucosal lymphatic channels facilitate longitudinal (cranial/caudal) spread before outward extension — explaining skip metastases

Lymph Node Staging (TNM 8th Edition Principles)

• N1: 1–2 regional lymph nodes
• N2: 3–6 regional lymph nodes
• N3: ≥7 regional lymph nodes
• Staging is based on number, not location, of involved nodes
• Node characteristics favoring malignancy: hypoechoic, rounded, irregular borders
• Lymph node fields are classified as: cervical, mediastinal, and abdominal — three-field involvement carries the worst prognosis

T-Staging with EUS

• EUS is the most important modality for mediastinal invasion assessment
• Anterior invasion: trachea, bronchus, pericardium, cardiac chambers
• Posterior invasion: aorta, azygos vein, prevertebral fascia, spine, diaphragmatic crura
• Lateral invasion: pleura and lung

3. Specific Clinical Data, Statistics, and Study Results Cited

• Esophageal cancer is the 8th most common cancer worldwide
• Histological subtypes: adenocarcinoma (~90%) and squamous cell carcinoma
• Skip metastases to para-aortic and distant nodal stations are common due to submucosal longitudinal spread
• CT scan has limited utility in T1 staging and local mediastinal assessment
• High-frequency EUS (26 MHz, tissue harmonic imaging) detected liver metastases missed by CT scan — confirmed by FNA
• Adrenal metastases are frequently identified incidentally on EUS in esophageal cancer patients
• Adenocarcinoma metastasizes predominantly to intra-abdominal sites; squamous cell carcinoma to intrathoracic sites
• EUS-guided tangential wall biopsy can be used when standard FNA is technically difficult
• Lymph node stations referenced per IASLC classification (stations 1R/L, 2R/L, 4R/L, 5–9, 10–14)

4. Practical Takeaways for Clinicians

• Always stage before treatment: EUS provides unique information on T-stage, mediastinal invasion, and nodal status that CT/PET may miss
• Count lymph nodes, not just locate them: N-stage is number-dependent; document all suspicious nodes and characterize their echogenicity and morphology
• Perform FNA of suspicious nodes in accessible stations (e.g., 4R, subcarinal) to confirm malignancy, particularly when CT is negative